Revelstoke Capital Partners has announced a recapitalization of AOM Infusion.
AOM, founded in 1994 and based in Fort Worth, Texas, is a specialty infusion provider focused on chronic therapy management.
Revelstoke, founded in 2013 and based in Denver, focuses on investing in the healthcare and related business services sectors. The firm typically commits between $25 million and $350 million in equity per transaction.
Terms of the investment were not disclosed.